Specifically, high expression of WISP2 mRNA was correlated with longer OS in stage 2 (HR = 0.37, p = 0.01) and longer RFS in stage 1 (HR = 0.5, p = 0.013) in HCC patients. This evidence concerns the gene CCN5 and hepatocellular carcinoma.